openPR Logo
Press release

New Study Reveals Cutaneous Squamous cell Carcinoma-Market Insights, Epidemiology and Market Forecast-2023

05-17-2017 12:27 PM CET | Health & Medicine

Press release from: Cutaneous Squamous cell Carcinoma-Market

New Study Reveals Cutaneous Squamous cell Carcinoma-Market

Researchmoz added Most up-to-date research on "Cutaneous Squamous cell Carcinoma-Market Insights, Epidemiology and Market Forecast-2023" to its huge collection of research reports.

DelveInsights Cutaneous Squamous Cell Carcinoma (cSCC)- Market Insights, Epidemiology and Market Forecast-2023-7MM report provides an overview of the disease and global market size of the Cutaneous Squamous Cell Carcinoma for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the Incident cases of Cutaneous Squamous Cell Carcinoma from 2013-2023.

Cutaneous Squamous Cell Carcinoma is a keratinocytic or non-melanoma skin cancer. cSCC is considered the second most common human malignancy after basal cell carcinoma (BCC).Actinic keratosis is the premalignant precursor for cSCC and early treatment might reduce patient morbidity. Unlike almost all basal-cell carcinomas, cutaneous squamous cell carcinomas are associated with a substantial risk of metastasis. The prognosis is favorable and only 2-5% of SCC metastasize.

According to DelveInsight, the market size for Cutaneous Squamous Cell Carcinoma of 7MM is estimated to be USD XX Million by 2023 at a CAGR of 6.1% for the forecast period i.e., 2013-2023.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1069400

Scope
The report will help in developing business strategies by understanding the trends shaping and driving the Cutaneous Squamous Cell Carcinoma market.Organize sales and marketing efforts by identifying the best opportunities for Cutaneous Squamous Cell Carcinoma in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.

To understand the future market competition in the 7MM of Cutaneous Squamous Cell Carcinoma and Insightful review of the key market drivers and barriers.

The report provides historical as well as forecasted epidemiology of Cutaneous Squamous Cell Carcinoma in the 7MM.
To understand the regulatory scenario in major markets

The Report also covers the detailed historical and forecasted Cutaneous Squamous Cell Carcinoma market covering United States, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2023.

Table Of Content

Report Introduction 2
Cutaneous Squamous Cell Carcinoma (cSCC) Market Overview at a Glance 8
7 Major Market Size of Cutaneous Squamous Cell Carcinoma (cSCC) (2013-2023) 8
Total Market Share Distribution of Cutaneous Squamous Cell Carcinoma for 7MM in 2016 9
Total Market Share Distribution of Cutaneous Squamous Cell Carcinoma for 7MM in 2023 9
Introduction 10
Signs and Symptoms 10
Pathophysiology 10
Sub-types of cSCC 12
Risk Factors 13
Staging of cSCC 15
Diagnosis 16
Epidemiology and Patient Population 18
Total number of Incident cases 7MM Countries (2016 & 2023) 19
United States 20
Germany 22
France 23
United Kingdom 25
Spain 27
Italy 28
Japan 30
Treatment Algorithm 32
United States 32
NCCN Guidelines 32
Europe 35
British Association of dermatology (BAD) Guidelines 35
French Dermatology Recommendations Association (aRED) 36
European Dermatology Forum 37
London Cancer Skin Pathway Board 39
National Cancer Institute 40
Unmet Needs 41
Marketed Drugs 42
5-Fluorouracil (5-FU) 42
MOA 42
Study 42
Xeloda 44
MOA 44
Study 44
Cisplatin 45
MOA 45
Study 45

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1069400

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New Study Reveals Cutaneous Squamous cell Carcinoma-Market Insights, Epidemiology and Market Forecast-2023 here

News-ID: 540052 • Views:

More Releases for Carcinoma

Neuroendocrine Carcinoma Market Size - Forecasts to 2026
The findings reviewed by GME stated that the Global Neuroendocrine Carcinoma Market will expand with a CAGR value of 10.6 percent from 2021 to 2026. Owing to a rise in the prevalence of neuroendocrine tumors (NETs) across the globe, the global neuroendocrine carcinoma market will grow rapidly during 2021-2026 forecast period. Browse the Report @ https://www.globalmarketestimates.com/market-report/global-neuroendocrine-carcinoma-market-3109 By Site (Gastrointestinal, Lung, Brain, Pancreas, and Others), By Therapy (Surgery, Radiation Therapy, and Chemotherapy), By
Global Merkel Cell Carcinoma Treatment Market Insights, Forecast
Merkel Cell Carcinoma, a skin malignancy, is caused by the uncontrolled development of Merkel cells in the skin. MCC was originally first described by Toker in 1972. The malady is to a great extent caused by Merkel Cell Polyomavirus (MCV) on parts of the skin in the head, neck and arms, generally occurs most often on sun-exposed areas of the skin. The global Merkel Cell Carcinoma Treatment market is
Breast Cancer Market Enthralling Growth CAGR at 9.2% with Unique Types Ductal Ca …
Market Research Future Published a Prime Research Report on “Global Breast Cancer Market Research Report - Forecast to 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023. Global Breast Cancer Market - Scenario:  Brest cancer is type of cancer developed in breast tissue. Formation of lump in a breast, red patches on the skin are the some of the common symptoms of the breast cancer. Obesity, lack of physical
Hepatocellular Carcinoma Drugs Market Opportunity Analysis, 2018-2026
Hepatocellular carcinoma (HCC) is a major type of primary liver cancer that arises from the liver cells or hepatocytes. The disease is found to occur mainly in patients with hepatitis B, hepatitis C, cirrhosis, obesity, and diabetes. Diagnosis of hepatocellular carcinoma is mainly done by imaging tests such as ultrasound, MRI, CT scan, and liver biopsy. Treatment for hepatocellular carcinoma mainly includes radiation therapy, ablation therapy in addition to chemotherapy
Neuroendocrine Carcinoma Market Analysis & Key Trends 2020
A neuroendocrine tumor is a kind of tumor that begins in the hormone producing cells of the neuroendocrine system that is made up of the endocrine system and nervous system. Hormones producing neuroendocrine cells have a structure similar to neurons and produce hormones like endocrine cells. These cells are found throughout the body in organs such as intestines, kidneys, lungs and stomach and perform functions such as controlling the speed
Merkel Cell Carcinoma - Pipeline Review, H1 2017
Market Research Hub includes new market research report "Merkel Cell Carcinoma - Pipeline Review, H1 2017" to its huge collection of research reports. Merkel cell carcinoma is a rare aggressive skin cancer that is at high risk of recurring and spreading (metastasizing) throughout the body. Risk factors for Merkel cell carcinoma include age, gender, light skin color, Ultraviolet exposure and immune suppression. Symptom includes painless nodule on skin. It usually starts